FDA Inspection 1307626 — Rafael Morales Barrera, MD
The FDA completed an inspection of Rafael Morales Barrera, MD on March 4, 2026 in Barcelona. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 4, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Barcelona (Spain)
Additional Details
Clinical Investigator (CI)